HTRA1
Serine protease HTRA1
Also known as: ARMD7, HtrA, HTRA1_HUMAN, IGFBP5-protease, PRSS11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92743
- Gene
- HTRA1
- Ensembl
- ENSG00000166033
- Chromosome
- 10
- Canonical length
- 480 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>Q92743|HTRA1
1 MQIPRAALLP LLLLLLAAPA SAQLSRAGRS APLAAGCPDR CEPARCPPQP EHCEGGRARD
61 ACGCCEVCGA PEGAACGLQE GPCGEGLQCV VPFGVPASAT VRRRAQAGLC VCASSEPVCG
121 SDANTYANLC QLRAASRRSE RLHRPPVIVL QRGACGQGQE DPNSLRHKYN FIADVVEKIA
181 PAVVHIELFR KLPFSKREVP VASGSGFIVS EDGLIVTNAH VVTNKHRVKV ELKNGATYEA
241 KIKDVDEKAD IALIKIDHQG KLPVLLLGRS SELRPGEFVV AIGSPFSLQN TVTTGIVSTT
301 QRGGKELGLR NSDMDYIQTD AIINYGNSGG PLVNLDGEVI GINTLKVTAG ISFAIPSDKI
361 KKFLTESHDR QAKGKAITKK KYIGIRMMSL TSSKAKELKD RHRDFPDVIS GAYIIEVIPD
421 TPAEAGGLKE NDVIISINGQ SVVSANDVSD VIKRESTLNM VVRRGNEDIM ITVIPEEIDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HTRA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 751 nTPM
Expression across tissuesHPA
Tissue
- ovary: 751 nTPM
- basal ganglia: 597 nTPM
- blood vessel: 591 nTPM
- amygdala: 462 nTPM
- midbrain: 430 nTPM
- cerebral cortex: 393 nTPM
Single-cell type
- podocytes: 617 nCPM
- retinal horizontal cells: 531 nCPM
- müller glia: 431 nCPM
- oligodendrocyte progenitor cells: 316 nCPM
- microglia: 311 nCPM
- extravillous trophoblasts: 292 nCPM
Immune cell
- classical monocyte: 0.4 nTPM
- memory CD4 T-cell: 0.3 nTPM
- gdT-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- white matter: 390 nTPM
- midbrain: 366 nTPM
- basal ganglia: 343 nTPM
- medulla oblongata: 329 nTPM
- pons: 318 nTPM
- thalamus: 318 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HTRA1.
Disease | AllUniProt
Conditions HTRA1 is implicated in, by any mechanism.
- Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 2 (CARASIL2) MIM:600142
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 (CADASIL2) MIM:616779
Disease | GeneticClinVar
40 pathogenic / likely-pathogenic of 377 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
- CARASIL syndrome
- HTRA1-related cerebral small vessel disease
- HTRA1-related disorder
- HTRA1-related autosomal dominant cerebral small vessel disease
ReferencesPubMed · IEDB
Publications for HTRA1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy.
2021 · J Am Soc Nephrol · RCR 6.9 · 93 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chorionic trophoblast cell differentiation
- negative regulation of BMP signaling pathway
- negative regulation of transforming growth factor beta receptor signaling pathway
- placenta development
- positive regulation of apoptotic process
- programmed cell death
- proteolysis
Molecular functions
- growth factor binding
- identical protein binding
- molecular function activator activity
- serine-type endopeptidase activity
- serine-type peptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Insulin-like growth factor-binding protein, IGFBP
- PDZ domain
- Peptidase S1C
- Kazal domain
- Peptidase S1, PA clan
- Growth factor receptor cysteine-rich domain superfamily
- PDZ superfamily
- Kazal domain superfamily
- PDZ domain 6
- Insulin-like growth factor binding protein
- Kazal-type serine protease inhibitor domain
- Trypsin-like peptidase domain
- PDZ domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HTRA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HTRA1 as an antibody target. Whether an autoantibody or antibody against HTRA1 could matter depends on whether native HTRA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HTRA1 is annotated at the cell surface, where native HTRA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HTRA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...